prostate cancer

Analyzing Medivation’s Growth Opportunity with Xtandi
Yahoo/Market Realist
Thu, 05/12/16 - 04:42 pm
Medivation
Xtandi
metastatic castration-resistant prostate cancer
prostate cancer
Shifting prostate landscape underpins Sanofi’s Medivation offer
EP Vantage
Fri, 04/29/16 - 09:15 am
prostate cancer
Sanofi
Medivation
M&A
Xtandi
J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal
Fierce Biotech
Wed, 04/6/16 - 09:51 am
JNJ
prostate cancer
Tesaro
niraparib
FDA green light sets Nanobiotix up to start nanoparticle prostate cancer trial
Fierce Biotech
Thu, 01/7/16 - 08:54 am
Nanobiotix
prostate cancer
FDA
NBTXR3
nanoparticle therapy
Can Lightning Strike Three Times? Prostate Cancer Drug Developer Gets $53M to Find Out
Forbes
Wed, 12/2/15 - 09:32 am
prostate cancer
ORIC Pharmaceuticals
OncoGenex shares fall after release of prostate cancer study data
Marketwatch
Wed, 12/2/15 - 09:25 am
OncoGenex
prostate cancer
custirsen
Aeterna Zentaris Rises on Finalized Marketing Agreement
24/7 Wall St
Tue, 12/1/15 - 01:04 pm
Aeterna Zentaris
Armune BioScience
Apifiny
prostate cancer
AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
Fierce Biotech
Fri, 10/30/15 - 11:17 am
AstraZeneca
olaparib
Lynparza
prostate cancer
ovarian cancer
Shares in Bavarian Nordic dip after short seller posts broadside against its cancer vaccine
Fierce Biotech
Wed, 08/5/15 - 08:59 am
Bavarian Nordic
vaccines
Prostvac
prostate cancer
​How Tokai Pharmaceuticals is using precision medicine for prostate cancer
Bizjournals.com
Mon, 08/3/15 - 09:39 pm
Tokai
prostate cancer
precision medicine
personalized medicine
galeterone
Why Shares in Medivation Inc. Tumbled Over 10% in June
Motley Fool
Sun, 07/12/15 - 09:34 am
Medivation
Xtandi
prostate cancer
Astellas, Medivation to amp up unbranded Xtandi marketing for pre-chemo use
Fierce Pharma Marketing
Wed, 06/17/15 - 10:24 am
Astellas
Medivation
Xtandi
drug marketing
prostate cancer
NICE sings a different tune for Bayer's prostate cancer drug Xofigo
Fierce Pharma
Fri, 06/5/15 - 11:03 am
NICE
Bayer
prostate cancer
Xofigo
OncoGenex Regains Rights to Custirsen from Teva
Yahoo
Mon, 04/27/15 - 09:43 am
OncoGenex
custirsen
Teva Pharmaceutical
lung cancer
prostate cancer
Are Sales for This J&J Drug About to Stall?
Investopedia
Mon, 04/13/15 - 09:59 pm
JNJ
Zytiga
prostate cancer
Medivation's Xtandi Beats Casodex In Cancer Trial
Investors.com
Fri, 04/3/15 - 08:38 am
Medivation
Xtandi
Casodex
Astellas
prostate cancer
Bristol-Myers forges a billion-dollar cancer vaccine deal with Bavarian Nordic
Fierce Biotech
Wed, 03/4/15 - 08:34 am
Bavarian Nordic
Bristol-Myers Squibb
vaccines
prostate cancer
Can Valeant transform Dendreon's ailing Provenge into a viable cancer competitor?
Fierce Pharma Marketing
Wed, 02/11/15 - 12:04 pm
Valeant Pharmaceuticals
Dendreon
Provenge
prostate cancer
OncoGenex to Regain Rights to Custirsen from Teva
Yahoo
Tue, 12/30/14 - 10:27 am
OncoGenex
Teva Pharmaceutical
custirsen
lung cancer
prostate cancer
Aeterna Zentaris: Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin in Prostate Cancer Published in Clinical Cancer Research
Yahoo
Mon, 12/29/14 - 09:34 am
Aeterna Zentaris
prostate cancer
zoptarelin doxorubicin

Pages